台灣臨床試驗主持人資料庫|TPIDB

2019-03-01 - 2022-12-31

Phase III

A Phase 3, double-blind, multicenter, placebo-controlled study of PledOx used on top of modified FOLFOX6 (5?FU/FA and Oxaliplatin) to prevent chemotherapy induced peripheral neuropathy (CIPN) in patients with first-line metastatic colorectal cancer

Condition/Disease

Prevent chemotherapy-induced peripheral neuropathy (CIPN)
Test Drug

PledOx

Participate Sites
4Sites

Terminated3Sites

王照元

Kaohsiung Municipal Gangshan Hospital

未分科

2019-03-01 - 2021-12-31

Phase III

A Phase 3, double-blind, multicenter, placebo-controlled study of PledOx used on top of modified FOLFOX6 (5-FU/FA and Oxaliplatin) to prevent chemotherapy induced peripheral neuropathy (CIPN) in the adjuvant treatment of patients with Stage III or high-risk Stage II colorectal cancer

Condition/Disease

Prevention of chemotherapy induced peripheral neuropathy (CIPN) (chemotherapy induced peripheral neuropathy)
Test Drug

PledOx

Participate Sites
4Sites

Terminated3Sites

王照元

Kaohsiung Municipal Gangshan Hospital

未分科

2017-10-01 - 2021-12-31

Phase II

Phase II, Randomized, Double-blind, Clinical Tial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan

Condition/Disease

Dengue
Test Drug

tetravalent live attenuated dengue vaccine admixture TV005

Participate Sites
4Sites

Not yet recruiting2Sites

Terminated1Sites

陳彥旭

Kaohsiung Municipal Gangshan Hospital

未分科

2019-04-01 - 2022-05-31

Phase III

A Phase 3, randomized, double-blind, parallel-group, placebo controlled multicenter study to evaluate the efficacy and safety of two doses of GLPG1690 in addition to local standard of care for minimum 52 weeks in subjects with idiopathic pulmonary fibrosis.

Condition/Disease

idiopathic pulmonary fibrosis
Test Drug

GLPG1690 (G451990)

Participate Sites
5Sites

Recruiting4Sites

許超群

Kaohsiung Municipal Gangshan Hospital

未分科

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

2017-08-01 - 2020-12-31

Phase III

HERO: A Multinational Phase 3 Randomized, Open-label, Parallel Group Study to Evaluate the Safety and Efficacy of Relugolix in Men with Advanced Prostate Cancer

Condition/Disease

Advanced Prostate Cancer
Test Drug

Relugolix 120 mg

Participate Sites
5Sites

Terminated4Sites

黃書彬

Kaohsiung Municipal Gangshan Hospital

未分科

2015-05-01 - 2023-04-24

Phase III

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation

Condition/Disease

Multiple Myeloma
Test Drug

Ixazomib (MLN9708)

Participate Sites
4Sites

Terminated3Sites

蕭惠樺

Kaohsiung Municipal Gangshan Hospital

未分科

2017-11-01 - 2021-12-31

Others

A Phase 2, Open-label Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment(OAV) in Virologically Suppressed Chronic Hepatitis B Subjects with Renal and/or Hepatic Impairment

Condition/Disease

Chronic viral hepatitis B
Test Drug

Vemlidy Film-coated tablet

Participate Sites
10Sites

Terminated9Sites

莊萬龍

Kaohsiung Municipal Gangshan Hospital

未分科

林俊彥

Linkou Chang Gung Medical Foundation

2017-03-17 - 2023-03-17

Phase III

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)

Condition/Disease

Nonalcoholic Steatohepatitis
Test Drug

Selonsertib

Participate Sites
5Sites

Terminated4Sites

黃志富

Kaohsiung Municipal Gangshan Hospital

未分科

沈一嫻

Linkou Chang Gung Medical Foundation

Division of General Internal Medicine

2017-03-03 - 2023-02-28

Phase III

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Condition/Disease

Nonalcoholic Steatohepatitis(NASH)
Test Drug

Selonsertib

Participate Sites
20Sites

Terminated18Sites

黃志富

Kaohsiung Municipal Gangshan Hospital

未分科

沈一嫻

Linkou Chang Gung Medical Foundation

Division of General Internal Medicine

2017-03-21 - 2020-07-21

Phase III

A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25 mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed

Condition/Disease

Chronic Hepatitis B
Test Drug

Tenofovir Alafenamide Tablets

Participate Sites
7Sites

Terminated5Sites

莊萬龍

Kaohsiung Municipal Gangshan Hospital

未分科

Search Result

List